Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
ELOVL4 Blocking Peptide (AC1243)
Cat.#: ACPP-1243
Specifications
Despition ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1558 Human ALK/P80 Protein (AC1558) 2 µg inquiry ACPP-1275 Usherin Blocking Peptide (AC1275) 250 µg inquiry ACPP-1827 Human NHLH2 Protein (AC1827) 2 µg inquiry ACPP-1102 Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) (AC1102) 50 µg inquiry ACPP-1790 Rat MANF Protein (AC1790) 5 µg inquiry ACPP-1117 Human BDNF Protein (AC1117) 2 µg inquiry ACPP-1286 Bestrophin 2 Blocking Peptide (AC1286) 250 µg inquiry ACPP-1335 Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) 250 µg inquiry ACPP-1766 Human HMGA2 Protein (AC1766) 2 µg inquiry ACPP-1352 Myocilin Blocking Peptide (AC1352) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket